Phone
022 6663 8000
FAX
022 6663 8120
Email
info@bluecrosslabs.com
Contact Us

K-VOG Tablets

COMPOSITIONK-VOG 0.2 mg TabletsEach Uncoated Tablet Contains:Voglibose0.2 mg K-VOG 0.3 mg TabletsEach Uncoated Tablet Contains:Voglibose0.3 mg INDICATIONS1. Prevention of onset of type 2 DM in subjects with impaired glucose tolerance (IGT).
2. Improvement of postprandial hyperglycemia in diabetes mellitus.DOSAGE AND ADMINISTRATIONOral: Adults: 0.2 – 0.3 mg three times a day before each meal, or as prescribed.HOW SUPPLIED10 Tablets per strip.